Aridis Pharmaceuticals 2020 Investor Presentation

Aridis Pharmaceuticals presented its investment thesis for novel anti-infective therapies targeting lung infections. The presentation outlines the company's clinical development pipeline and addresses key risk factors associated with regulatory approval, clinical trial execution, and market commercialization in the competitive biopharmaceutical space.